Sökning: WFRF:(Boström Adrian Desai E.)
> (2022) >
HPA-axis dysregulat...
-
Boström, Adrian Desai E.Umeå universitet,Psykiatri,Department of Women's and Children's Health/Neuropediatrics, Karolinska Institutet, Stockholm, Sweden
(författare)
HPA-axis dysregulation is not associated with accelerated epigenetic aging in patients with hypersexual disorder
- Artikel/kapitelEngelska2022
Förlag, utgivningsår, omfång ...
-
Elsevier,2022
-
electronicrdacarrier
Nummerbeteckningar
-
LIBRIS-ID:oai:DiVA.org:uu-478630
-
https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-478630URI
-
https://doi.org/10.1016/j.psyneuen.2022.105765DOI
-
http://kipublications.ki.se/Default.aspx?queryparsed=id:149854881URI
-
https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-194405URI
Kompletterande språkuppgifter
-
Språk:engelska
-
Sammanfattning på:engelska
Ingår i deldatabas
Klassifikation
-
Ämneskategori:ref swepub-contenttype
-
Ämneskategori:art swepub-publicationtype
Anmärkningar
-
BackgroundHypersexual disorder (HD) - a nonparaphilic sexual desire disorder with impulsivity component - was evaluated for inclusion as a diagnosis in the DSM-5 and the diagnosis compulsive sexual behavior disorder is included as an impulse control disorder in the ICD-11. Hypothalamic-pituitary-adrenal (HPA)-axis hyperactivity is believed to affect cellular senescence and has been implicated in HD. No previous study investigated HD or HPA-axis dysregulation in relation to measures of epigenetic age (EA) acceleration.MethodsThis study reports on a case-control study set-up from a well-characterized cohort, contrasting EA predictors in relation to 60 HD patients and 33 healthy volunteers (HV) and 19 mixed HD/HV exhibiting dexamethasone suppression test (DST) non-suppression to 73 mixed HD/HV DST controls. The genome-wide methylation pattern was measured in whole blood from 94 subjects using the Illumina Infinium Methylation EPIC BeadChip and preprocessed according to specialized protocols suitable for epigenetic age estimation. The online DNAm Age Calculator (https://dnamage.genetics.ucla.edu/) was implemented to retrieve various EA predictors, which were compared between the in-silico generated subgroups.ResultsQuality control analyses indicated strong correlations between the EA measure DNA methylation GrimAge (DNAm GrimAge – the EA clock most reliably associated with mortality risk) and chronological age in all sub-groups. The study was adequately powered to detect differences of 2.5 and 3.0 years in DNAm GrimAge minus age in relation to both HD and HPA-axis dysregulation, respectively. Baseline DNAm GrimAge exceeded chronological age by 2.8 years on average across all samples. No EA acceleration marker was associated with HD or DST suppression status (p > 0.05).ConclusionEA acceleration markers shown to be strongly predictive of physiological dysregulation and mortality-risk, are not related to HD or DST non-suppression status (measured after 0.5 mg dexamethasone). The independency of HPA-axis dysregulation to EA acceleration does not support the biological relevance of this dosage-regimen when applied to patients with HD. These findings do not support the notion of accelerated cellular senescence in HD. Studies stratifying DST non-suppressors according to established dosage-regimens in somatic settings are needed to fully elucidate the putative contribution of HPA-axis dysregulation to EA.
Ämnesord och genrebeteckningar
Biuppslag (personer, institutioner, konferenser, titlar ...)
-
Andersson, PeterKarolinska Institutet,Department of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden; Centre for Clinical Research Dalarna, Uppsala University, Falun, Sweden
(författare)
-
Chatzittofis, AndreasUmeå universitet,Psykiatri,Medical School, University of Cyprus, Nicosia, Cyprus(Swepub:umu)anch0141
(författare)
-
Savard, JosephineUmeå universitet,Psykiatri(Swepub:umu)joesad04
(författare)
-
Rask-Andersen, Mathias,1979-Uppsala universitet,Medicinsk genetik och genomik,Science for Life Laboratory, SciLifeLab,Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden(Swepub:uu)matra895
(författare)
-
Öberg, Katarina G.Karolinska Univ Hosp, Anova, Stockholm, Sweden.;Karolinska Inst, Dept Med, Stockholm, Sweden.,Anova, Karolinska University Hospital, Stockholm, Sweden; Department of Medicine, Karolinska Institutet, Stockholm, Sweden
(författare)
-
Arver, StefanKarolinska Univ Hosp, Anova, Stockholm, Sweden.;Karolinska Inst, Dept Med, Stockholm, Sweden.,Anova, Karolinska University Hospital, Stockholm, Sweden; Department of Medicine, Karolinska Institutet, Stockholm, Sweden
(författare)
-
Jokinen, JussiUmeå universitet,Karolinska Institutet,Psykiatri,Department of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden(Swepub:umu)jujo0022
(författare)
-
Umeå universitetPsykiatri
(creator_code:org_t)
Sammanhörande titlar
-
Ingår i:Psychoneuroendocrinology: Elsevier1410306-45301873-3360
Internetlänk
Hitta via bibliotek
Till lärosätets databas